Raymond James & Associates’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-42,713
| Closed | -$1.2M | – | 4087 |
|
|
2022
Q1 | $1.2M | Buy |
42,713
+2,717
| +7% | +$76.1K | ﹤0.01% | 2468 |
|
|
2021
Q4 | $1.09M | Buy |
39,996
+4,045
| +11% | +$110K | ﹤0.01% | 2560 |
|
|
2021
Q3 | $978K | Buy |
+35,951
| New | +$978K | ﹤0.01% | 2597 |
|
|
2018
Q3 | – | Sell |
-10,208
| Closed | -$382K | – | 3593 |
|
|
2018
Q2 | $382K | Buy |
10,208
+1,756
| +21% | +$65.7K | ﹤0.01% | 2850 |
|
|
2018
Q1 | $332K | Sell |
8,452
-81,822
| -91% | -$3.21M | ﹤0.01% | 2816 |
|
|
2017
Q4 | $2.93M | Sell |
90,274
-2,747
| -3% | -$89K | 0.01% | 1440 |
|
|
2017
Q3 | $2.9M | Buy |
93,021
+5,264
| +6% | +$164K | 0.01% | 1383 |
|
|
2017
Q2 | $2.45M | Buy |
87,757
+1,744
| +2% | +$48.7K | 0.01% | 1433 |
|
|
2017
Q1 | $1.48M | Buy |
86,013
+7,838
| +10% | +$134K | ﹤0.01% | 1729 |
|
|
2016
Q4 | $946K | Sell |
78,175
-9,918
| -11% | -$120K | ﹤0.01% | 1949 |
|
|
2016
Q3 | $1.4M | Sell |
88,093
-32
| -0% | -$507 | ﹤0.01% | 1672 |
|
|
2016
Q2 | $1.14M | Buy |
88,125
+7,013
| +9% | +$90.6K | ﹤0.01% | 1665 |
|
|
2016
Q1 | $1.54M | Buy |
81,112
+19,153
| +31% | +$364K | 0.01% | 1438 |
|
|
2015
Q4 | $1.39M | Buy |
61,959
+34
| +0.1% | +$765 | 0.01% | 1455 |
|
|
2015
Q3 | $1.45M | Buy |
+61,925
| New | +$1.45M | 0.01% | 1397 |
|